Using HIV clinics in Zambia to provide cervical cancer prevention through HPV vaccination
Leveraging HIV infrastructure to implement cervical cancer prevention: A study to integrate HPV vaccination in adolescent HIV clinics in Zambia
This study is working to help young people with HIV in Zambia get the HPV vaccine to prevent cervical cancer by offering it at their clinics, making it easier for them to receive all three doses in a supportive environment.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10911963 on NIH RePORTER |
What this research studies
This research aims to improve cervical cancer prevention in Zambia by integrating HPV vaccination into adolescent HIV clinics. Given the high prevalence of HIV and the associated increased risk of cervical cancer, the study focuses on ensuring that adolescents living with HIV receive the recommended three doses of the HPV vaccine. By leveraging existing healthcare infrastructure, the project seeks to reach vulnerable populations, particularly those who may not have access to traditional school-based vaccination programs. The approach involves regular contact with adolescents in these clinics, providing a trusted environment for health education and vaccination.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 9-14 living with HIV in Zambia.
Not a fit: Patients who are not adolescents or do not have HIV may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of cervical cancer among adolescents living with HIV in Zambia.
How similar studies have performed: Similar approaches have shown promise in other low- and middle-income countries, indicating potential for success in this context.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Hunleth, Jean Marie — Washington University
- Study coordinator: Hunleth, Jean Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.